Pangaea Oncology, S.A.

BME:PANG Stock Report

Market Cap: €51.5m

Pangaea Oncology Future Growth

Future criteria checks 1/6

Pangaea Oncology is forecast to grow earnings and revenue by 46.9% and 18.7% per annum respectively while EPS is expected to grow by 52.3% per annum.

Key information

46.9%

Earnings growth rate

52.3%

EPS growth rate

Life Sciences earnings growth21.7%
Revenue growth rate18.7%
Future return on equityn/a
Analyst coverage

Low

Last updated03 May 2024

Recent future growth updates

Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

May 17
Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Feb 01
Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Recent updates

Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Nov 09
Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

May 17
Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Feb 01
Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Earnings and Revenue Growth Forecasts

BME:PANG - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261600N/A1
12/31/202515-1-1-11
12/31/202414-1-2-21
12/31/202311-1-3-31
6/30/20237-3-4-3N/A
3/31/20237-3-4-4N/A
12/31/20227-3-4-4N/A
9/30/20227-2-3-3N/A
6/30/20227-2-3-3N/A
3/31/20227-1-3-3N/A
12/31/20217-1-3-3N/A
9/30/20217-1-2-2N/A
6/30/20217-1-2-2N/A
3/31/20216-1-2-2N/A
12/31/20206-2-2-2N/A
9/30/20206-3-2-2N/A
6/30/20206-4-3-3N/A
3/31/20206-4-3-2N/A
12/31/20196-5-2-2N/A
9/30/20196-3-2-2N/A
6/30/20195-2-1-1N/A
3/31/20196-1-2-2N/A
12/31/20186-1-2-2N/A
9/30/20186-2-4-3N/A
6/30/20186-2-5-5N/A
3/31/20186-2-6-6N/A
12/31/20176-2-7-6N/A
9/30/20176-1-6-5N/A
6/30/20175-1-4-4N/A
3/31/20175-1N/A-3N/A
12/31/20165-1N/A-2N/A
9/30/20165-1N/A-2N/A
6/30/201650N/A-2N/A
3/31/201640N/A-2N/A
12/31/201540N/A-2N/A
12/31/201420N/A-2N/A
12/31/201330N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PANG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: PANG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: PANG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: PANG's revenue (18.7% per year) is forecast to grow faster than the Spanish market (3.9% per year).

High Growth Revenue: PANG's revenue (18.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PANG's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.